Recent Updates
Recently added Catalysts
KEQU

Unassociated Document Kewaunee Scientific Announces Higher Third Quarter Sales and Earnings and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC

Key Takeaway: Scientific Announces Third Quarter Sales and Earnings Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 NC, February 26, 2009-Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2009. earnings for the

Full Press Release Details

Scientific Announces
Third Quarter Sales and Earnings
Exchange: NASDAQ (KEQU) Contact: D. Michael Parker
704/871-3290
NC, February 26, 2009-Kewaunee Scientific Corporation (NASDAQ: KEQU) today
announced results for its third quarter ended January 31, 2009.
earnings for the quarter increased to $882,000, or $0.35 per diluted share, up
10% from $802,000, or $0.31 per diluted share, in the same period last year.
Earnings benefited from the higher sales volume, solid operational performances
throughout the Company, and the stabilization of costs for key raw materials and
energy. Net earnings for the nine months ended January 31, 2009 were $3,327,000,
or $1.30 per diluted share, up 24% from net earnings of $2,688,000, or $1.05 per
diluted share, in the same period last year.
the quarter were $26,023,000, up 19% over sales of $21,883,000 in the same
period last year. Sales benefited from continuing higher levels of new orders
and the record order backlog. Sales for the nine months ended January
31, 2009 were $79,150,000, up 17% from sales of $67,394,000 in the same period
from domestic operations during the quarter were $22,498,000, up 27% from the
same period last year. Domestic sales for the nine months ended January 31, 2009
were $67,296,000, an increase of 21% from the same period last year. Sales from
international operations were $3,525,000, down 17% from the same period last
year. The decline resulted primarily from a softer Singapore laboratory
furniture market. International sales for the nine months ended January 31, 2009
were $11,854,000, up 2% from the same period last year.
backlog at January 31, 2009 was $60.7 million, up from $58.8 million at January
31, 2008, and down slightly from $61.6 million at the end of the previous
quarter. The domestic marketplace for laboratory furniture products
provided an extremely high number of opportunities during the quarter, and the
Company had one of the strongest quarters of quotation activity in its history.
Although some slowing of activity in the Asian laboratory marketplace was noted
during the quarter, the Company closed two significant orders in Asia that added
to the order backlog.
Company's financial condition continues to be strong. Bank borrowings and
capital lease obligations were $6,318,000 at January 31, 2009, up from
$4,243,000 at January 31, 2008, with the increase primarily the result of
receivables associated with the increase in sales. Cash on hand was $3,089,000,
as compared to $2,882,000 at the end of the same period last year. Working
capital was $17,749,000 at the end of the quarter, up from $14,671,000 at the
end of the same period last year.
pleased with the Company's strong performance during the third quarter," said
William A. Shumaker, President and Chief Executive Officer. "Our
strategic efforts over the past several years to make Kewaunee a more efficient
Company are working well. We have not yet noticed any significant
impact from the global economic slowdown on our business or opportunities in the
domestic laboratory furniture marketplace, but we remain keenly aware of this
serious situation. We are diligently pursuing a number of
strategies that will help position the Company in case of an economic downturn
in our industry and, at the same time, make the Company even stronger when the
believe the Company is on track for a good fourth quarter. Sales
should benefit from our strong order backlog, and earnings should benefit from
lower costs for some of our key raw materials and our on-going cost reduction
activities. We expect aggressive competitive pricing will continue, and probably
accelerate, in the coming months."
Company also announced today that its Board of Directors approved a cash
dividend of eight cents per outstanding share to stockholders of record at the
close of business on March 12, 2009, payable on March 26, 2009.
Scientific Corporation is a recognized leader in the design, manufacture, and
installation of scientific and technical furniture. The Company's corporate
headquarters and domestic manufacturing facilities are located in Statesville,
North Carolina. The Company has subsidiaries in Singapore and
Bangalore, India that serve the Asian and Middle East
markets. Kewaunee Scientific's website is located at
statements in this release constitute "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and
Statements of Operations
thousands, except per share data)
Three Months Ended Nine Months Ended
January 31 January 31
2009 2008 2009 2008
Net sales $ 26,023 $ 21,883 $ 79,150 $ 67,394
Cost of products sold 21,089 17,064 62,846 52,759
Gross profit 4,934 4,819 16,304 14,635
Operating expenses 3,440 3,293 10,884 9,811
Operating earnings 1,494 1,526 5,420 4,824
Other income (expense) 3 (6 ) (36 ) (2 )
Interest expense (49 ) (86 ) (231 ) (302 )
Earnings before income taxes 1,448 1,434 5,153 4,520
Income tax expense 488 421 1,595 1,391
Earnings before minority interests 960 1,013 3,558 3,129
Minority interests 78 211 231 441
Net earnings $ 882 $ 802 $ 3,327 $ 2,688
Net earnings per share
Basic $ 0.35 $ 0.32 $ 1.30 $ 1.07
Diluted $ 0.35 $ 0.31 $ 1.30 $ 1.05
Weighted average number of common shares outstanding (in thousands)
Basic 2,556 2,543 2,554 2,523
Diluted 2,556 2,576 2,563 2,551
Consolidated Balance Sheets
January 31 April 30
2009 2008
(unaudited)
Assets
Cash and cash equivalents $ 2,691 $ 3,784
Restricted cash 398 480
Receivables, less allowances 24,723 20,087
Inventories 7,678 6,984
Prepaid expenses and other current assets 1,359 1,847
Total current assets 36,849 33,182
Net property, plant and equipment 11,601 11,825
Other assets 5,064 5,599
Total Assets $ 53,514 $ 50,606
Liabilities and Stockholders' Equity
Short-term borrowings $ 5,815 $ 4,551
Current obligations under capital leases 268 323
Accounts payable 8,211 8,929
Other current liabilities 4,806 3,459
Total current liabilities 19,100 17,262
Other non-current liabilities 5,295 6,397
Total stockholders' equity 29,119 26,947
Total Liabilities and Stockholders' Equity $ 53,514 $ 50,606
Last updated: Feb 26, 2009